References
- B.LíviaC.P.BarbosaM.A.SilvanaK.RobertoL.EmyB.AdelarA.CiomarEffects of simvastatin, atorvastatin, ezetimibe, and ezetimibe + simvastatin combination on the inflammatory process and on the liver metabolic changes of arthritic ratsFundam. Clin. Pharmacol.262012722734
- F.EzzetG.KrishnaD.B.WexlerP.StatkevichT.KosoglouV.K.BatraA population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibeClin. Ther.232001871885
- R.SistlaV.S.TataY.V.KashyapD.ChandrasekarP.V.DiwanDevelopment and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage formsJ. Pharm. Biomed. Anal.392005517522
- H.MohamedA.MohammedJ.SaeedRapid and sensitive simultaneous determination of ezetimibe and simvastatin from their combination drug products by monolithic silica high-performance liquid chromatographic columnJ. Pharm. Biomed. Anal.502009527534
- S.SaranjitS.BaljinderB.RakeshW.LalitS.RahulStress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assayJ. Pharm. Biomed. Anal.41200510371040
- S.D.AshishK.K.PankajS.J.HemendraValidation of a stability-indicating LC method for assay of ezetimibe in tablets and for determination of content uniformityChromatographia672008137142
- B.G.ChaudhariN.M.PatelP.B.ShahL.J.PatelV.P.PatelStability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug productsJ. AOAC Int.90200715391546
- B.G.ChaudhariN.M.PatelP.B.ShahStability-indicating reversed-phase liquid chromatographic method for simultaneous determination of simvastatin and ezetimibe from their combination drug productsJ. AOAC Int.90200712421249
- M.V.MahadikS.R.DhaneshwarApplication of a stability-indicating HPTLC method for the quantitative determination of ezetimibe in pharmaceutical dosage formsAsian J. Pharm. Sci.22007182190
- L.D.SérgioR.O.PauloB.ThiagoT.VítorDevelopment and validation of a stability-indicating micellar electrokinetic chromatography method for the determination of ezetimibe in pharmaceutical formulationsAnal. Sci.242008499503
- S.ZsuzsannaK.JanosS.KatalinV.KrisztinaS.CsabaJr.Structure of the major degradant of ezetimibeJ. Pharm. Biomed. Anal.582012125129
- G.SrikanthK.UttamN.MuraliP.BadrinadhJ.VundavilliD.SatheeshI.AminulIdentification, isolation and characterization of process related impurities in ezetimibeJ. Pharm. Biomed. Anal.252014385390
- R.BhanuA.S.BrajeshB.RahulD.G.PradeepK.AshokStructural elucidation of a process-related impurity in ezetimibe by LC/MS/MS and NMRJ. Pharm. Biomed. Anal.5220107378
- International Conferences on Harmonization Q2 (R1). Validation of analytical procedures: text and methodology, 2005.